《中国期刊全文数据库》收录期刊
《中国核心期刊(遴选)数据库》收录期刊
《中文科技期刊数据库》收录期刊
Original article

Significance of P504s, P63, PSMA, and Ck34βE12 in identification of benign and malignant prostate lesions

  • LI Guocheng
Expand
  • Department of Surgery, Traditional Chinese Medicine Hospital of Heze City of Shandong Province, Heze 274000, China

Received date: 2018-03-28

  Online published: 2019-12-10

Abstract

Objective To explore the significance of P504s, P63, PSMA, and Ck34βE12 in the identification of benign and malignant prostate lesions.Methods A total of 112 surgical resection specimens of transrectal ultrasound guided prostate biopsy were collected from the Traditional Chinese Medicine Hospital of Heze City of Shandong Province from January 2014 to December 2016.All specimens were prepared for paraffin section and detected for P504s, P63, PSMA, and Ck34βE12.According to the proportion of positive cells, the detection Results were classified as follows.The accuracy, sensitivity, and specificity of P504S, P63, PSMA, and Ck34βE12 detected separately and jointly in the diagnosis of prostate cancer were compared.Results The positive rate of P504s in prostate cancer patients was 100.00%, and the dispersion positive rate was up to 62.75%, significantly higher than those in the AAH, BCH, and BPH patients.The positive rates of P63 and Ck34βE12 in prostate cancer patients were both 0%, while those in the HGPIN, AAH, BCH, and BPH patients were all 100.00%.The positive rates of PSMA in prostate cancer and HGPIN patients were 98.04% and 90.91%, respectively, while those in the AAH, BCH, and BPH patients were 13.33%, 11.11%, and 9.52%, respectively.The accuracy, sensitivity, and specificity of combined detection of P504s, P63, PSMA, and Ck34 reached 100.00%, 97.85%,and 98.24%, respectively, showing clinical diagnostic value.Conclusion For the diagnosis of prostate cancer, combined detection of P504s, P63, PSMA, and Ck34βE12 could significantly increase the accuracy, sensitivity, and specificity.

Cite this article

LI Guocheng . Significance of P504s, P63, PSMA, and Ck34βE12 in identification of benign and malignant prostate lesions[J]. Surgical Research and New Technique, 2018 , 7(2) : 93 -96 . DOI: 10.3969/j.issn.2095-378X.2018.02.004

References

[1] 叶定伟,朱耀.中国前列腺癌的流行病学概述和启示[J].中华外科杂志, 2015,53(4):249-252.
[2] 马志伟,董丹丹,龚百生,等.P504S在前列腺癌、肾细胞癌和膀胱尿路上皮癌中的表达及临床意义[J].临床与病理杂志, 2015,35(7):1276-1281.
[3] 孙文国,夏利,蒋雷鸣,等.TMPRSS2-ERG、AMACR和p63在前列腺癌中的表达及相关性[J].安徽医科大学学报, 2012,47 (11):1351-1355.
[4] 刘蓉,路名芝,谢绮.前列腺癌中PSMA、PSCA的表达与病理分级、骨转移和预后的关系及其临床意义[J].实用临床医学, 2012,13 (2) :136-138.
[5] 魏国华,高志安.特异AT序列结合蛋白1和P504s在前列腺癌中的表达及临床意义[J].中国现代医学杂志, 2015,25 (23):32-34.
[6] Tucci P, Agostini M, Grespi F, et al.Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer.[J].P Natl Acad SCI USA, 2014,111 (7):2855-2855.
[7] 秦桂萍,华玉兰,侯海娜.前列腺癌组织p504S和p63与血清PSA表达水平相关性分析[J].中华肿瘤防治杂志, 2013,20 (3):200-202.
[8] 温爽,盖宇,宗华凤,等.前列腺癌组织P504S、E-Cadherin和bcl-2蛋白表达及意义[J].大连医科大学学报, 2013,35 (2):25-28.
[9] 胡四龙,许晓平,朱耀,等.~(99m)Tc标记PSMA小分子抑制剂靶向前列腺癌分子影像初步临床研究[J].中国癌症杂志, 2016,26(7):608-615.
[10] Ben JA, Bouraoui Y, Oueslati R.Insight into the heterogeneity of prostate cancer through PSA-PSMA prostate clones:mechanisms and consequences.[J].Histol Histopathol, 2014,29(10):1263-1280.
Outlines

/